Regulation of lung fibroblast activation by annexin A1

Journal of Cellular Physiology

Volumn 228, Issue 2, 2013, Pages 476-484

  Jia, Yuan ^a,b   Morand, Eric F ^a   Song, Wuqi ^a,c   Cheng, Qiang ^a   Stewart, Alastair ^d   Yang, Yuan H ^a  

^a MONASH UNIVERSITY   (Australia)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; INTERFERON PRODUCTION; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A1; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; LUNG; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PNEUMONIA; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868014744     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24156     Document Type: Article

References (55)

1. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE. 1999. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 274:37620-37628.
2. Alves VA, Nonogaki S, Cury PM, Wunsch-Filho V, de Carvalho MB, Michaluart-Junior P, Moyses RA, Curioni OA, Figueiredo DL, Scapulatempo-Neto C, Parra ER, Polachini GM, Silistino-Souza R, Oliani SM, Silva-Junior WA, Nobrega FG, Tajara EH, Zago MA. 2008. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology 53:715-727.
3. Asselin-Labat ML, David M, Biola-Vidamment A, Lecoeuche D, Zennaro MC, Bertoglio J, Pallardy M. 2004. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104:215-223.
4. Asselin-Labat ML, Biola-Vidamment A, Kerbrat S, Lombes M, Bertoglio J, Pallardy M. 2005. FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol Endocrinol 19:1752-1764.
5. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, Nusrat A. 2006. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281:19588-19599.
6. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, Capaldo CT, Peatman E, Severson EA, Flower RJ, Perretti M, Parkos CA, Nusrat A. 2008. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181:5035-5044.
7. Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JY, Ryu SH. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 173:607-614.
8. Beaulieu E, Morand EF. 2011. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev Rheumatol 7:340-348.
9. Beaulieu E, Ngo D, Santos L, Yang YH, Smith M, Jorgensen C, Escriou V, Scherman D, Courties G, Apparailly F, Morand EF. 2010. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum 62:2651-2661.
10. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, Persico P. 1980. Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147-149.
11. Chapman L, Nishimura A, Buckingham JC, Morris JF, Christian HC. 2002. Externalization of annexin I from a folliculo-stellate-like cell line. Endocrinology 143:4330-4338.
12. Clark AR, Lasa M. 2003. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 3:404-411.
13. Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M. 2008. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 112:2512-2519.
14. Damazo AS, Yona S, D'Acquisto F, Flower RJ, Oliani SM, Perretti M. 2005. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 166:1607-1617.
15. Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM. 2006. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol 176:4410-4418.
16. Damazo AS, Sampaio AL, Nakata CMAG, Flower RJ, Perretti M, Oliani SM. 2011. Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis. BMC Immunol 12:59.
17. Davies E, Omer S, Morris JF, Christian HC. 2007. The influence of 17beta-estradiol on annexin 1 expression in the anterior pituitary of the female rat and in a folliculo-stellate cell line. J Endocrinol 192:429-442.
18. Fiore S, Maddox JF, Perez HD, Serhan CN. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med 180:253-260.
19. Frohn M, Xu H, Zou X, Chang C, McElvaine M, Plant MH, Wong M, Tagari P, Hungate R, Burli RW. 2007. New "chemical probes" to examine the role of the hFPRL1 (or ALXR) receptor in inflammation. Bioorg Med Chem Lett 17:6633-6637.
20. Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold HG. 2008. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9:1189-1197.
21. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP. 2004. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164:73-79.
22. Gastardelo TS, Damazo AS, Dalli J, Flower RJ, Perretti M, Oliani SM. 2009. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol 174:177-183.
23. Goulding NJ. 2004. The molecular complexity of glucocorticoid actions in inflammation-A four-ring circus. Curr Opin Pharmacol 4:629-636.
24. Grugan KD, Ma C, Singhal S, Krett NL, Rosen ST. 2008. Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma. J Steroid Biochem Mol Biol 110:244-254.
25. -/- mouse. FASEB J 17:253-255.
26. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M. 2006. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: Indication of distinct receptor involvement. Blood 107:2123-2130.
27. Kam AY, Tse TT, Kwan DH, Wong YH. 2007. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells. Cell Signal 19:2106-2117.
28. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. 2002. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 8:117-123.
29. Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, Anderson RL, Stewart AG. 2011. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J 25:483-496.
30. Kurosu K, Takiguchi Y, Okada O, Yumoto N, Sakao S, Tada Y, Kasahara Y, Tanabe N, Tatsumi K, Weiden M, Rom WN, Kuriyama T. 2008. Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis. J Immunol 181:756-767.
31. Le Y, Gong W, Li B, Dunlop NM, Shen W, Su SB, Ye RD, Wang JM. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163:6777-6784.
32. Miele L, Cordella-Miele E, Facchiano A, Mukherjee AB. 1988. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 335:726-730.
33. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. 1995. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 76:195-1202.
34. Morand EF, Hall P, Hutchinson P, Yang YH. 2006. Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1. Mediators Inflamm 2006:73835.
35. Mulla A, Leroux C, Solito E, Buckingham JC. 2005. Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab 90:557-562.
36. Parente L, Solito E. 2004. Annexin 1: More than an anti-phospholipase protein. Inflamm Res 53:125-132.
37. Perretti M, Christian H, Wheller SK, Aiello I, Mugridge KG, Morris JF, Flower RJ, Goulding NJ. 2000. Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int 24:163-174.
38. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8:1296-1302.
39. Profita M, Bonanno A, Siena L, Bruno A, Ferraro M, Montalbano AM, Albano GD, Riccobono L, Casarosa P, Pieper MP, Gjomarkaj M. 2009. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J Pharmacol Exp Ther 329:753-763.
40. Sawmynaden P, Perretti M. 2006. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem Biophys Res Commun 349:1351-1355.
41. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA. 2005. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 326:218-227.
42. Shin MK, Jang YH, Yoo HJ, Kang DW, Park MH, Kim MK, Song JH, Kim SD, Min G, You HK, Choi KY, Bae YS, Min do S. 2011. N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow. J Biol Chem 286:17133-17143.
43. Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, Wang JM. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189:395-402.
44. Tagoe CE, Marjanovic N, Park JY, Chan ES, Abeles AM, Attur M, Abramson SB, Pillinger MH. 2008. Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts. J Immunol 181:2813-2820.
45. Toh ML, Yang Y, Leech M, Santos L, Morand EF. 2004. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: Up-regulation by interleukin-1beta and glucocorticoids. Arthritis Rheum 50:3118-3128.
46. VanCompernolle SE, Clark KL, Rummel KA, Todd SC. 2003. Expression and function of formyl peptide receptors on human fibroblast cells. J Immunol 171:2050-2056.
47. Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C, Bours V. 2007. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem Pharmacol 73:1982-1994.
48. Wu SH, Wu XH, Lu C, Dong L, Chen ZQ. 2006. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am J Respir Cell Mol Biol 34:65-72.
49. Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, Han YL, Chen BS, Wei F, Qian XH, Cai YY, Shen Y, Wu M, Wang MR. 2002. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 21:6641-6648.
50. Yang YH, Morand EF, Getting SJ, Paul-Clark M, Liu DL, Yona S, Hannon R, Buckingham JC, Perretti M, Flower RJ. 2004. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum 50:976-984.
51. Yang YH, Toh ML, Clyne CD, Leech M, Aeberli D, Xue J, Dacumos A, Sharma L, Morand EF. 2006. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1. J Immunol 177:8148-8153.
52. Yang N, Zhang W, Shi XM. 2008. Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J Cell Biochem 103:1760-1771.
53. Yang YH, Aeberli D, Dacumos A, Xue JR, Morand EF. 2009. Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J Immunol 183:1435-1445.
54. Yoneda K, Yamamoto T, Ueta E, Osaki T. 1997. Azelastine hydrochloride (Azeptin) inhibits peplomycin (PLM)-induced pulmonary fibrosis by contradicting the up-regulation of signal transduction. Anti-Cancer Drug Des 12:577-590.
55. Zhang Z, Huang L, Zhao W, Rigas B. 2010. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70:2379-2388.